Amer Renal Assoc Analysis
Amer Renal Assoc is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Amer Renal delisted stock analysis is to determine its intrinsic value, which is an estimate of what Amer Renal Assoc is worth, separate from its market price. There are two main types of Amer Renal's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Amer Renal's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Amer Renal's stock to identify patterns and trends that may indicate its future price movements.
The Amer Renal stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Amer Renal is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Amer Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Amer Renal's ongoing operational relationships across important fundamental and technical indicators.
Amer |
Amer Stock Analysis Notes
About 81.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.41. Amer Renal Assoc recorded a loss per share of 0.52. The entity had not issued any dividends in recent years. The firm had 2:1 split on the April 30, 2012. American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. The company was founded in 1999 and is headquartered in Beverly, Massachusetts. American Renal operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 4977 people. For more info on Amer Renal Assoc please contact Joseph Carlucci at 978 922-3080 or go to www.americanrenal.com.Amer Renal Assoc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Amer Renal's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Amer Renal Assoc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Amer Renal Assoc is not yet fully synchronised with the market data | |
| Amer Renal Assoc has some characteristics of a very speculative penny stock | |
| Amer Renal Assoc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 814.1 M. Reported Net Loss for the year was (16.86 M) with profit before taxes, overhead, and interest of 254.5 M. | |
| Over 81.0% of the company shares are held by institutions such as insurance companies |
Amer Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 397.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amer Renal's market, we take the total number of its shares issued and multiply it by Amer Renal's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Amer Profitablity
Amer Renal's profitability indicators refer to fundamental financial ratios that showcase Amer Renal's ability to generate income relative to its revenue or operating costs. If, let's say, Amer Renal is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Amer Renal's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Amer Renal's profitability requires more research than a typical breakdown of Amer Renal's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (1.11) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 9.73 %, which entails that for every 100 dollars of revenue, it generated $9.73 of operating income.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Amer Renal to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Amer Stock
If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |